Editas Medicine stock dips on proposed equity offering
Source: SeekingAlpha
2026-05-26 06:53:20 ET
More on Editas Medicine
- Editas Medicine, Inc. (EDIT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
- Editas Medicine GAAP EPS of -$0.06 beats by $0.20, revenue of $24.74M beats by $15.97M
- Seeking Alpha’s Quant Rating on Editas Medicine
- Historical earnings data for Editas Medicine
- Financial information for Editas Medicine
Read the full article on Seeking Alpha
For further details see:
Editas Medicine stock dips on proposed equity offering
Editas Medicine Inc.
NASDAQ: EDIT
EDIT Trading
-11.99% G/L:
$2.68 Last:
1,155,498 Volume:
$2.97 Open:
EDIT Latest News
May 31, 2026 12:31:48 pm
CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?
May 28, 2026 04:01:00 pm
Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference
EDIT Stock Data
$174,737,401
95,568,668
0.4%
71
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
